Title: Initial Phase 3 Results Of The First (Frontline Investigation Of Lenalidomide plus Dexamethasone Versus Standard Thalidomide) Trial (MM-020/IFM 07 01) In Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible For Stem Cell Transplantation (SCT)
Authors: Facon, Thierry
Dimopoulos, Meletios A
Dispenzieri, Angela
Catalano, John V
Belch, Andrew R
Hulin, Cyrille
Cavo, Michele
Pinto, Antonella
Weisel, Katja
Ludwig, Heinz
Bahlis, Nizar J
Banos, Anne
Tiab, Mourad
Delforge, Michel
Cavenagh, James D
Geraldes, Catarina
Lee, Je-Jung
Chen, Christine I
Oriol, Albert
De La Rubia, Javier
Qiu, Lugui
White, Darrell J
Binder, Daniel
Anderson, Kenneth C
Moreau, Philippe
Attal, Michel
Knight, Robert
Chen, Guang
Van Oostendorp, Jason
Jacques, Christian J
Ervin-Haynes, Annette
Benboubker, Lofti
Issue Date: 2013
Host Document: BLOOD vol:122 issue:21
Conference: 55th Annual Meeting of the American-Society-of-Hematology location:New Orleans: LA date:DEC 07-10, 2013
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Stem Cell Biology and Embryology (+)

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.